25th Jan 2005 11:10
Lazard & Co., Ltd (Panmure Gordon)25 January 2005 EMM DISCLOSURE FORM 38.5 (SUMMARY) Lodge with a RIS and the Takeover Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EMMLazard & Co., Limited (Panmure Gordon) Date of disclosure25 January 2005 Contact nameTom Forcier Telephone number020 7187 2252 Please see attached disclosure of dealings under Rule 38,5 in the securities of the following companies: Oxford Biomedica Plc AMENDMENT If the attached Rule 38.5 disclosure is to amend a previous disclosure, please state which element(s) of previous disclosure was incorrect: In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the nature of the dealings can be fully understood. For options this should include the number of securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or received. For derivatives this should include, at least, the number of reference securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference price. For full details of the disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring Section of the Panel, Tel No: 020 7638 0129. Email: monitoring@disclosure,org.uk FORM 38.5 CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in (name of company)Oxford Biomedica Plc Class of securityOrdinary shares Date of disclosure25 January 2005 Date of dealing24 January 2005 Name of EMMLazard & Co., Limited (Panmure Gordon) Name of offeree/offerer with whom connectedOxford Biomedica plc Total number of securities purchased4,000,000 Highest price paid*22.25p Lowest price paid*22p Total number of securities sold4,000,000 Highest price received*22.25p Lowest price received*22p *currency must be stated This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica